![Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis – Is there a difference? - Leiherer - 2021 - Journal of Internal Medicine - Wiley Online Library Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis – Is there a difference? - Leiherer - 2021 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1c3fa122-39eb-46ff-9aec-41422d531b16/joim13368-gra-0001-m.jpg)
Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis – Is there a difference? - Leiherer - 2021 - Journal of Internal Medicine - Wiley Online Library
![Hand Writing Inscription Atherosclerosis with Marker, Concept Stock Image - Image of whiteboard, health: 198281753 Hand Writing Inscription Atherosclerosis with Marker, Concept Stock Image - Image of whiteboard, health: 198281753](https://thumbs.dreamstime.com/z/hand-writing-inscription-atherosclerosis-marker-concept-black-198281753.jpg)
Hand Writing Inscription Atherosclerosis with Marker, Concept Stock Image - Image of whiteboard, health: 198281753
![Hand Writing Inscription Atherosclerosis With Marker Concept Stock Photo - Download Image Now - iStock Hand Writing Inscription Atherosclerosis With Marker Concept Stock Photo - Download Image Now - iStock](https://media.istockphoto.com/id/649742180/photo/hand-writing-inscription-atherosclerosis-with-marker-concept.jpg?s=612x612&w=0&k=20&c=deEqFQyS5lT7aNRopKtmzRz8qifsofbej1brBST9pvE=)
Hand Writing Inscription Atherosclerosis With Marker Concept Stock Photo - Download Image Now - iStock
![JCI - Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis JCI - Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis](https://dm5migu4zj3pb.cloudfront.net/manuscripts/57000/57275/medium/JCI57275.f5.jpg)
JCI - Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
![Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study | Journal of the American College of Cardiology Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/7cd12241-69f5-4ae1-aea2-feb23471a8ba/gr1.jpg)
Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study | Journal of the American College of Cardiology
![Complement C5 Protein as a Marker of Subclinical Atherosclerosis | Journal of the American College of Cardiology Complement C5 Protein as a Marker of Subclinical Atherosclerosis | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/d0ccd59c-d11d-42c3-8197-540fc1dd696e/fx1.jpg)
Complement C5 Protein as a Marker of Subclinical Atherosclerosis | Journal of the American College of Cardiology
Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability | PLOS ONE
![PDF] New markers of atherosclerosis: a threshold level of heteroplasmy in mtDNA mutations | Semantic Scholar PDF] New markers of atherosclerosis: a threshold level of heteroplasmy in mtDNA mutations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a5c7c0701a67ff2e24249838049232afaa8878cc/5-Table1-1.png)
PDF] New markers of atherosclerosis: a threshold level of heteroplasmy in mtDNA mutations | Semantic Scholar
![Targeting inflammation in atherosclerosis — from experimental insights to the clinic | Nature Reviews Drug Discovery Targeting inflammation in atherosclerosis — from experimental insights to the clinic | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41573-021-00198-1/MediaObjects/41573_2021_198_Fig1_HTML.png)